Call for an instant quote
0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
27 June 2016 08:57
Thousands of new skin cancer cases are diagnosed every year
Over 1,000 Welsh and English skin cancer patients could receive a revolutionary new, life-prolonging drug combination that has been fast-tracked for use in the NHS.
The Yervoy (ipilimumab) and Opdivo (nivolumab) mixture uses the body's immune system to fight tumours.
Tests show that over six in 10 of 95 skin cancer sufferers given the treatment remained alive two years later. Of these, 22% were tumour-free.
Few drugs have ever been approved faster in the history of the NHS.
Nice sanctioned the drugs just weeks after the European Medicines Agency granted them a licence.
The combination is targeted at patients suffering from melanoma which has dispersed throughout their bodies.
Scientists say the pair can ward off advanced melanoma's development by a typical eight months in contrast with conventional treatment.
Experts believe that roughly 1,300 patients could qualify to use these immunotherapy drugs each year.
Both drugs are called "checkpoint inhibitors". These disturb two separate signalling pathways and basically free up a person's immune system to tackle tumours.
These inhibitors are known to cause liver damage, diarrhoea and other side-effects, however.
Patients diagnosed with the disease need not rule out holidays abroad, especially if they take out skin cancer-related travel insurance.
Policies comprise round-the-clock medical help and replacement medication.
• Melanoma claims 1,750 English lives each year
• Latest stats show that 12,200 new cases of skin cancer were detected in 2013
• Skin cancer sufferers can typically only expect to live under two years after being diagnosed.
17 February 2017
Comedian David Baddiel is trying to highlight the "epidemic" of dementia as a killer of older people in a new documentary.
16 February 2017
The public has spoken and the world's favourite cruises are being honoured by a top cruise review site.
15 February 2017
The collaborative #SkiSafe campaign has been relaunched in a bid to raise safety awareness among winter sports enthusiasts.
14 February 2017
A new "age defying" hormone could offer a breakthrough in preventing kidney and heart disease in people who suffer from diabetes.
11 February 2017
Patients needing new life-saving medication could have to wait two years after the UK leaves the EU, experts are warning.
10 February 2017
Families looking to take a cheap break in the upcoming half term are often sorely disappointed, however new research suggests Cyprus is the best destination for a well-priced trip.
09 February 2017
Europe remains the world's number one region as a travel destination - but tourism growth is slowing down, a travel industry report has said.
08 February 2017
A terminal cancer patient is determined to fulfil his dream of climbing Mount Everest, despite having just months to live.
07 February 2017
One third of holidaying families will opt for a British break this year, new research suggests.
04 February 2017
The benefits of treating back pain with medication could be outweighed by the longer-term side effects, a study suggests.
03 February 2017
Better connectivity in the north of England would see millions more air passengers pass through the region, an independent commission has found.
02 February 2017
An innovative technique to link breast cancer cell shapes to changes in genes could help scientists identify treatments much sooner.